Statin Trials, Cardiovascular Events, and Coronary Artery Calcification
- 1 February 2018
- journal article
- research article
- Published by Elsevier in JACC: Cardiovascular Imaging
- Vol. 11 (2) , 221-230
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- What Works and in Whom?Circulation: Cardiovascular Quality and Outcomes, 2012
- Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort studyThe Lancet, 2011
- A Zero Coronary Artery Calcium ScoreJACC, 2010
- Number Needed to Treat With Rosuvastatin to Prevent First Cardiovascular Events and Death Among Men and Women With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive ProteinCirculation: Cardiovascular Quality and Outcomes, 2009
- Cardiovascular events with absent or minimal coronary calcification: The Multi-Ethnic Study of Atherosclerosis (MESA)American Heart Journal, 2009
- Absence of Coronary Artery Calcification and All-Cause MortalityJACC: Cardiovascular Imaging, 2009
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- A strategy to reduce cardiovascular disease by more than 80%BMJ, 2003
- Multi-Ethnic Study of Atherosclerosis: Objectives and DesignAmerican Journal of Epidemiology, 2002
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995